John J. Kirby - 06 Nov 2024 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Role
Interim CFO
Signature
/s/ Christopher Hayes, Attorney-in-Fact
Issuer symbol
VRCA
Transactions as of
06 Nov 2024
Net transactions value
$0
Form type
4
Filing time
06 Nov 2024, 21:04:32 UTC
Previous filing
06 Nov 2024
Next filing
25 Nov 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRCA Common Stock Award $0 +54,267 $0.000000 54,267 06 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award. The RSUs shall vest vest in full on May 4, 2025, subject to the Reporting Person's continuous service through such date.